Beijing 90% of the medical examination center to carry out gastrointestinal tumor "three early" collaborative screening.

Early detection, early diagnosis, early treatment, Beijing Health Management Association gastrointestinal tumor "three early" collaborative screening project recently launched, the total incidence of gastrointestinal tumors accounted for about 20% of all cancer incidence, but in the physical examination as the representative of the tumor opportonistic screening, gastrointestinal tumor screening rate is almost zero.
The reason for this is that, on the one hand, most medical examination centers do not have the standard screening techniques for gastrointestinal tumors and the ability of gastroenteroscopy, on the other hand, most of the subjects fear invasive gastroenteroscopy, making gastrointestinal tumor screening very low compliance. Qiu Dalong, president of the Beijing Health Management Association, said that the establishment of an opportonic screening system for gastrointestinal tumors suitable for the application of China's medical examination centers is an urgent problem to be solved.
This launch of the "three early" collaborative screening program, not only developed a standard preliminary screening program for cancer species, and for the medical examination institutions to carry out promotion and standardization of training, while the Association organized the relevant screening equipment, supplies suppliers to provide preferential prices for the supply of medical examination institutions, to assist the medical examination institutions to carry out early screening services related to tumors.
survey, FIT test and fecal FIT-DNA method for colorectal cancer screening are recommended by the Expert Consensus on Early Diagnosis and Screening Strategies for Colorectal Tumors in China published by the Chinese Anti-Cancer Association. Professor Wang Guiqi, director of endoscopy at the Oncology Hospital of the Chinese Academy of Medical Sciences, said that the Consensus had been updated for the first time since 2012 and innovatively proposed a three-stage prevention and control path for colorectal cancer, namely, blood loss detection by selecting questionnaire risk assessment and immunological method. The first screening is carried out, and the positive person walks further to the multi-target fecal FIT-DNA joint test (Chang Weiqing), and then the positive person is examined for enteroscopy, and for some colorectal cancer screening programs, the multi-target fecal FIT-DNA test or intestinal mirror can also be carried out directly.
Wang Guiqi pointed out that the biggest breakthrough in the three-stage prevention and control path of colorectal cancer lies in the introduction of home-based multi-target feces FIT-DNA joint detection technology. The preliminary clinical verification data of the technology in the domestic population show that the sensitivity of bowel cancer is 97.5%, the sensitivity of advanced adenoma is 53.1%, and the specificity is 88.1%, which has good detection performance. The technology, which is included in the "Three Mornings" program, can improve the detection rate of enteroscopic tumors while reducing unnecessary colonoscopy.
another gold standard for the diagnosis of gastrointestinal tumors, endoscopy of the digestive tract combined with histological pathology. Zhang Yantian, director of Beijing Friendship Hospital, stressed that the ability to recognize early cancer and precancer lesions has a lot to do with the operation of endoscopy physicians, endoscopy operation should not focus on the pursuit of speed, but should pay attention to screening high-risk groups.
Zhang Kai, deputy director of the cancer prevention department of the Oncology Hospital of the Chinese Academy of Medical Sciences, said that the initial screening technology program promoted by the "Three Mornings" collaborative screening program has good screening effectiveness, enabling the medical examination center to detect as many high-risk groups of gastrointestinal tumors as possible by means of non-invasive compliance. To achieve "early detection", high-risk groups in the platform gastroenterology center to accept standardized gastroenteroscopy early screening means to achieve "early diagnosis", diagnosed early cancer and precancer lesions patients effectively referred to the main three hospitals, to achieve "early treatment."
It is understood that the "three early" collaborative screening project will gradually cover more than 90% of the medical examination centers in Beijing, the organization of the establishment of a professional expert committee on digestive tract tumors, will coordinate and establish an information referral platform, innovative introduction of accident insurance including missed diagnosis Including early diagnosis insurance, thus providing professional technical support for the medical examination center, referral platform support and missed diagnosis insurance protection, to solve the pain and difficulties of the medical examination center in the early screening of gastrointestinal tumors, to achieve the gastrointestinal tumor "sequent-through screening" of the early diagnosis strategy.
.